Modulation of lipid profile by fish oil and garlic combination

Journal of the National Medical Association

Volumn 89, Issue 10, 1997, Pages 673-678

  Morcos, N C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Western Medical Center   (United States)

Author keywords

Coronary artery disease; Fish oil; Garlic; Lipid profile

Indexed keywords

FISH OIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; FEMALE; GARLIC; HUMAN; HYPERLIPIDEMIA; MALE; MEDICINAL PLANT; MIDDLE AGED; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; FEMALE; FISH OILS; GARLIC; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANTS, MEDICINAL;

EID: 0031252466     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Drevon CA. Sources, chemistry and biochemistry of dietary lipids. In: Drevon CA, Baksas I, Krokan HE, eds. Omega-3 Fatty Acids Metabolism and Biological Effects. Basel, Switzerland: Birkhauser Verlag; 1993:110-210.
2. Mansell P, Reckless JPD. Garlic. Effects on serum lipids, blood pressure, coagulation, platelet aggregation and vasodialation. BMJ. 1991;303:379-380.
3. Bang HO, Dyerberg J, Nielsen AB. Plasma lipid and lipoprotein pattern in Greenlandic West-Coast Eskimos. Lancet. 1971;1:1143-1145.
4. Dyerberg J, Bang HO, Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr. 1975;28:958-966.
5. Kromhout D, Bosschieter EB, DeLezenne Coulander C. The inverse relation between fish consumption and 20 year mortality from coronary heart disease. N Engl J Med. 1985;312:1205-1209.
6. Bairati I, Roy L, Meyer F. Double-blind randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation. 1992;85:950-956.
7. Keli SO, Freskens EJM, Kromhout D. Is fish consumption inversely associated with stroke incidence? The Zuptkin study. Stroke. 1996;25:328-332.
8. Rustan AC, Nossen JO, Osmundsen H, Drevon CA. Eicosapentanoic acid inhibits cholesterol estrification in cultured rat hepatocytes. J Biol Chem. 1988;263:8126-8132.
9. Rustan AC, Nossen JO, Christiansen EC, Drevon CA. Eicosapentanoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A: 1,2 diacylglycerol acyltransferase. J Lipid Res. 1988;29:1417-1426.
10. Second International Garlic Symposium. Pharmacy, pharmacology and clinical application of allium sativum. Cardiology in Practice. 1991;(suppl):2-19.
11. Greenwood TW. Garlic therapy. Br J Clin Pract. 1990;44(suppl 69):1-2.
12. Jain AK, Vargas R, Gotzkowsky S, McMahon G. Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med. 1993;94:632-635.
13. Lau BHS, Adetumbim A, Sanchez A. Alium sativum and atherosclerosis: a review. Nutr Res. 1983;3:119-128.
14. Ernst E, Welhmayr TH, Matral A. Garlic and blood lipids. BMJ. 1985;291:139. Letter.
15. Kandziora I. Antihypertensive effectiveness and tolerance of garlic medication. Arztiche Forchung. 1988;1:1-8.
16. Kandziora I. The blood pressure lowering and lipid lowering effect of a garlic preparation in combination with a diuretic. Arztiche Forchung. 1988;3:1-8.
17. Harenberg J, Giese C, Zimmermann R. Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia. Atherosclerosis. 1988;74:247-249.
18. Mader FH. Treatment of hyperlipidemia with garlic-powder tablets. Evidence from the German Association of General Practitioners' multicenteric placebo-controlled double blind study. Arneimittelforschung. 1990;40:1111-1116.
19. Grunwald I. Garlic and cardiovascular risk factors. Br J Clin Pharmacol. 1990;29:582-583. Letter.
20. Auer W, Eiber A, Hertkorn E, Hoehfeld E, Koehrle H, Lorenz A. Hypertension and hyperlipidemia: garlic helps in mild cases. Br J Clin Pract. 1990;44(suppl 69):3-6.
21. Vorberg G, Schneider B. Therapy with garlic: results of a placebo-controlled double-blind study. Br J Clin Pract. 1990;44(suppl 69):7-11.
22. Brosche T, Platt D, Dorner H. The effect of a garlic preparation on the composition of plasma lipoproteins and erythrocyte membranes in geriatric subjects. Br J Clin Pract. 1990;44(suppl 69):12-19.
23. Zimmermann W, Zimmermann B. Reduction in elevated blood lipids in hospitalized patients by a standard garlic preparation. Br J Clin Pract. 1990;44(suppl 69):20-23.
24. Barrie SA, Wright JV, Pizzamo JE. Effects of garlic oil on platelet aggregation, serum lipids, and blood pressure in humans. Journal of Orthomolecular Medicine. 1987;2:15-21.
25. Bordia A. Effect of garlic on blood lipids in patients with coronary heart disease. Am J Clin Nutr. 1981;34:2100-2103.
26. Kiesewetter H, Jung F, Jung EM, Blume J, Mrowietz C, Birk E, et al. Effects of garlic coated tablets in peripheral arterial occlusive disease. Clinical Investigator. 1993;71:383-386.
27. Kiesewetter H, Jung F, Pindur G, Jung EM, Mrowietz C, Wenzel E. Effects of garlic on thrombocyte aggregation, microcirculation, and other risk factors. Int J Clin Pharmacol Ther Toxicol. 1991;29:151-155.
28. Jung F, Jung EM, Mrowietz C, Kiesewetter H. Wenzel E. Influence of garlic powder on cutaneous microcirculation: a randomized, placebo-controlled, double-blind, cross over study in apparently healthy subjects. Br J Clin Pract 1990;44(suppl 69):30-35.
29. Wolf S, Reim M. Effect of garlic on conjunctival vessels: a randomized, placebo-controlled, double blind trial. Br J Clin Pract. 1990;44(suppl 69):36-39.
30. Orekhov AN, Tertov W, Igor A, Pivovarova S, Pivovarova EM. Direct anti-atherosclerosis-related effects of garlic. Ann Med. 1995;27:63-6.5.
31. Mori TA, Vandongen R, Beilin LJ, Burke V, Morris J, Ritchie J. Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease. Am J Nutr. 1994;59:1060-1068.
32. Nordoy A, Hatcher LF, Ullmann D, Connor WE. Individual effects of dietary unsaturated fatty acids and fish oil on plasma lipids and lipoproteins in normal men. Am J Clin Nutr. 1993;57:634-639.
33. Kinsella JE. Seafoods and fish oils in human health and disease. In: Food Science and Technology. New York, NY: Marcel Dekker; 1987;23:1-37.
34. Budowski P. Omega 3 fatty acids in health and disease. In: Bourne GH, ed. Aspects of Human Nutrition-World Review of Nutrition and Dietetics. Basel, Switzerland: S Karger AG; 1988;57:214-274.
35. Goodnight SH. Mechanisms of the antithrombotic effects of fish oil. Baillieres Clin Haematol. 1990;3:601-623.
36. Herold PM, Kinsella JE. Fish oil consumption and decreased risk of cardiovascular disease: a comparison of animal and human feeding trials. Am J Clin Nutr. 1986;43:566-598.
37. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res. 1989;30:785-807.
38. Mori TA, Vandongen R, Masarei JRL, Stanton KG, Dunbar D. Dietary fish oils increase serum lipids in insulin-dependent diabetics compared to healthy controls. Metabolism. 1989;38:404-409.
39. Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR. Reduction of plasma lipids, lipoproteins and apoproteins by fish oils in patients with hypertriglyceridemia. N Eng J Med. 1985;312:1210-1216.
40. Mori TA, Vandongen R, Masarei JRL. Fish oil-induced changes in apolipoproteins in IDDM subjects. Diabetes Care. 1990;13:725-732.
41. Mori TA, Vandongen R, Masarei JRL, Rousse IL, Dunbar D. Comparison of diets supplemented with fish oil or olive oil on plasma lipoproteins in insulin dependent diabetics. Metabolism. 1991;40:241-246.
42. Mori TA, Vandongen R, Mahanian F, Douglas A. Plasma lipids, platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation. Metabolism. 1992;41:1059-1067.
43. Broshe T, Siegers CP, Platt O. The effects of garlic therapy on cholesterol biosynthesis and on plasma and membrane lipids. Medizinische Welt. 1991;42(suppl 7A):10-11.
44. Gebhardt R. Inhibition of cholesterol biosynthesis by a water soluble garlic extract in primary cultures of rat hepatocytes. Arzneimittelforschung. 1991;41:800-804.
45. Harris WS, Conner WE, Inkeles SB, Illingworth DR. Omega-3 fatty acids prevent carbohydrate-induced hypertriglyceridemia. Metabolism. 1984;33:1016-1019.
46. Nestel PJ, Connor WE, Reardon MR, Connor S, Wong S, Boston R. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest. 1984;74:72-89.
47. Sanders TAB, Sullivan DR, Reeve J. Thompson GR. Triglyceride lowering effect of marine polyunsaturates in patients with hypertryglyceridemia. Arteriosclerosis. 1985;5:459-465.
48. Conner WE. Hypolipidemic effects of dietary omega-3 fatty acids in normal and hyperlipedemic humans: effectiveness and mechanisms. In: Simopoulos AR, Kifer RR, Martin RE, eds. Health Effects of Polyunsaturated Fatty Acids in Seafoods. Orlando, Fla: Academic Press; 1986:173-210.
49. Harris WS, Connor WE, Illingworth DR, Rothrock DW, Foster DM. Effects of fish oil on triglyceride kinetics in humans. J Lipid Res. 1990;31:1549-1558.
50. Huff MW, Telford DE. Dietary fish oil increases the conversion of VLDL apoB to LDL apoB. Arteriosclerosis. 1989;9:58-66.
51. Sullivan DR, Sanders TAB, Trayner IM, Thompson GR. Paradoxical elevation of LDL apoprotein B levels in hyper triglyceridemic patients and normal subjects ingesting fish oil. Atherosclerosis. 1986;61:129-134.
52. Packard CJ, Monro A, Lorimer AR, Gotto AM, Shepherd J. Metabolism of apopolipoprotein B in large, triglyceride rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest. 1984;74:2178-2192.
53. Gianturco SH, Brown FB, Gotto AM, Bradley WA. Receptor mediated uptake of hypertriglyceridemic VLDL by normal human fibroblasts J Lipid Res. 1982;23:984-993.
54. Simmons LA, Blasubramaniam S, von Konigsmark M, Parfitt A, Simons J, Peters W. On the effects of garlic on plasma lipids and lipoproteins in mild hypercholesterolemia. Atherosclerosis. 1995;113:219-225.
55. Abdullah TH, Elkadi KA, Carter J. Garlic revisited: therapeutic for the major diseases of our times? J Natl Med Assoc. 1988;80:439-445.
56. Kauf E, Dawczynski H, Jahreis G, Janitzky E, Winnefeld K. Sodium selenite therapy and thyroid-hormone status in cystic fibrosis and congenital hypothyroidism. Biol Trace Elem Res. 1994;40:247-253.
57. Jacques PF, Sulsky SI, Perrone GA, Schaefer EJ. Ascorbic acid and plasma lipids. Epidemiology. 1994;5:19-26.
58. Bendich A, Langseth L. The health effects of vitamin C supplementation: a review. J Am Coll Nutr. 1995;14:124-136.
59. Adler AJ. Holub BJ. Effect of garlic and fish oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men. J Clin Nutr. 1997;65:445-450.